Seer Inc.

Seer Inc.

Market Cap (Mar-08-2026)
0.11 Billion USD
World Rank (Jan-05-2024)
20,465
Market Cap (Jan-05-2024)
0.121 Billion USD
World Rank (Jul-30-2023)
15,545
Market Cap (Jul-30-2023)
0.316 Billion USD
World Rank (Jan-07-2022)
8,690
Market Cap (Jan-07-2022)
1.151 Billion USD
World Rank (Jan-01-2021)
4,005
Market Cap (Jan-01-2021)
3.333 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
SEER
Employee Count
60
Employee Count as of Date
As on 2019
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
6 Million USD
Annual Net Income in USD
-71 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
539 Million USD
Total Liabilities in USD
36 Million USD
Total Equity in USD
502 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Company Website
SEER, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile

Seer Inc is a biotechnology sector company that develop innovative solutions that act as a gateway to the proteome. The headquarters is in USA.

The Seer approach combines proprietary engineered nanoparticles with an automated assay solution to provide an unmatched combination of unbiased, deep, rapid, and scalable workflow to give you a clearer view of the proteome.

The company annual net income is 16.0 million USD, annual revenue is 1.07 billion USD and 60 employees as on 2019. The headquarters is in USA.

IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Medicinal Chemicals and Botanical Products

Share